<DOC>
	<DOC>NCT01108419</DOC>
	<brief_summary>The aim of the study is to assess the safety and tolerance of a new fermented food versus a control product in healthy adults during the 4-week consumption period.</brief_summary>
	<brief_title>Evaluation of Dose-effect of a New Fermented Food in Healthy Adults</brief_title>
	<detailed_description />
	<criteria>Subjects after receiving a full description of the study, provide written informed consent to take part in the study. Freeliving subject, as evaluated during the clinical examination. Male/female subjects aged between 18 to 55 years (bounds included). Subjects with a body mass index (BMI) between 18.5 ≤ BMI &lt; 30kg/m². Healthy subjects (as determined by a medical examination) Subjects with any allergy (food, respiratory…). Subjects that have had any surgery or intervention requiring general anaesthesia in the last 4 weeks. Subjects with a history of chronic metabolic or gastrointestinal disease with the exception of appendectomy. Subjects with chronic or iatrogenic immunodeficiency (e.g. Chemotherapy, HIV). Subjects presenting a severe evolutive or chronic pathology (e.g. cancer,tuberculosis, Crohn's disease, cirrhosis, multiple sclerosis, Type I diabetes…). Subject with eating disorders. Subjects with cardiac, respiratory (including asthma) or renal insufficiency, cardiomyopathy, valvulopathy and medical history of rheumatic fever. Subjects with special medicated diet (for obesity, anorexia, metabolic pathology…). For female subjects: pregnancy, breastfeeding or not willing to use/not using an acceptable method of contraception Subject, in the Investigator's opinion, should not be randomised.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>healthy adults</keyword>
</DOC>